67
Views
11
CrossRef citations to date
0
Altmetric
Editorial

Pertussis vaccines: where to now?

, &
Pages 1497-1500 | Published online: 09 Jan 2014
 

Acknowledgements

The authors thank Joanne Wolter for assistance in preparation of the manuscript.

Financial & competing interests disclosure

Jan T Poolman is an employee of Crucell and is a designated inventor on a variety of patents owned by GlaxoSmithKline Biologicals S.A. (GSK). Scott A Halperin has received research support for undertaking clinical trials from both Sanofi Pasteur and GlaxoSmithKline, who are manufacturers of acellular pertussis vaccines, but has no financial interest in either company. Hans Hallander was involved in the 1990s Swedish NIH sponsored efficacy trial. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Writing assistance was utilized in the production of this manuscript and was funded by Crucell.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.